Khon Kaen, Thailand

Laddawan Chunchatprasert


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Khon Kaen, TH (1997 - 1998)
  • Khon, TH (1998)
  • Khon Kean, TH (2000)

Company Filing History:


Years Active: 1997-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Laddawan Chunchatprasert: Innovator in Antitumor Compounds**

Introduction

Laddawan Chunchatprasert is a prominent inventor based in Khon Kaen, Thailand. With an impressive portfolio of 4 patents, she has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-tumor activity.

Latest Patents

Her most recent patent focuses on antitumor tetracyclic compounds. This invention involves heterocyclic compounds that have shown notable anti-tumor activity. Specifically, it concerns pyrrolo[2,3-b]carbazoles and 1H-[1]benzothieno [2,3-f]indoles. The patent not only details methods for synthesizing these compounds but also encompasses pharmaceutical formulations containing them. One of the key advantages of these compounds is their low toxicity against normal cell lines while exhibiting effective anti-tumor cell activity.

Career Highlights

Throughout her career, Laddawan has been associated with reputable organizations, including University College Cardiff Consultants Limited and The Wellcome Foundation Limited. Her work in these institutions has provided her with a platform to innovate and advance her research in developing effective pharmaceutical agents.

Collaborations

Laddawan has collaborated with notable professionals in the field, including Patrick Vivian Shannon and David Drysdale Miller. These collaborations have enhanced her research outcomes and broadened the impact of her inventions in the pharmaceutical industry.

Conclusion

Laddawan Chunchatprasert continues to be an influential figure in the realm of pharmaceutical innovations, specifically in anti-tumor compounds. Her groundbreaking work has the potential to lead to significant advancements in cancer treatment, highlighting the importance of continued research and development in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…